MEDICA Newsletter
Social Media
More about…
- 3D printing and additive manufacturing
- Adiposity
- Age
- Alzheimer's
- Antibiotics
- Artificial intelligence
- Biocompatible
- Biomarker
- Biotechnology
- Blood
- Bones and skeleton
- Brain
- Brain Tumour
- Breast
- CT
- Cancer
- Cardiovascular diseases
- Care
- Cells
- Communication
- Dementia
- Depression
- Devices
- Diabetes
- Diagnostics
- Disinfection
- Drugs
- EEG
- EU
- Environment
- Epilepsy
- Eyes
- Financing
- Fitness
- Genetic material
- Genetics
- Germany
- Global health
- Gynecology
- Healthcare politics
- Heart
- Hospital
- Hospital information system
- Hygiene
- Imaging
- Immune system
- Implants
- Infectious diseases
- Information technology
- Intestine
- Kidney
- Knee
- Laboratory
- Laser
- Liver
- Lung
- MEDICA 2022
- MRI
- Mammography
- Materials
- Media
- Medical apps
- Medical market
- Microscopy
- Microtechnology
- Minimally invasive
- Multiple Sclerosis
- Nanotechnology
- Neurology
- Nuclear medicine
- Nutrition
- Optical technologies
- Optimisation
- Organs
- Orthopedics
- Pain
- Parkinson's
- Pathogens
- Pathology
- Patients
- Personalized Medicine
- Physiotherapy
- Pregnancy
- Prevention
- Prosthesis
- Psychology
- Radiology
- Regenerative Medicine
- Rehabilitation
- Research
- Risks
- Robotics
- SARS-CoV-2/COVID-19
- Safety
- Screening
- Screening
- Senses
- Skin
- Sleep
- Smart textiles
- Software
- Sports medicine
- Stem cells
- Sterilisation
- Surgery
- Surgical intervention
- Telemedicine
- Therapy
- Tissue engineering
- Transplantation
- Treatment
- Ultrasound
- Vaccination
- Virtual Reality and Augmented Reality
- Wearable technologies
- Women
- Wound care and wound healing
- X-ray devices
- eHealth
- mHealth
Medical University of Vienna
Locally advanced cervical cancer: Better odds using personalized brachytherapy
17/01/2023
For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of MedUni Vienna and Vienna General Hospital using data from the multicentre EMBRACE-I trial demonstrated the superiority of a targeted approach in brachytherapy.
Empa
Empa's Zukunftsfonds – Funding ambitious research: A chip to replace animal testing
24/11/2022
New drugs made from nanoparticles that can easily penetrate any interface within our bodies are a great hope in medicine. For such hopefuls to reach the market, their safety must be ensured. In this context, it must also be clarified what happens if a substance manages to penetrate the natural barrier between baby and mother, the placenta, in the body of pregnant women.
NomadSoul1
Possible biological explanation for increased cancer risk in dense breasts
04/11/2022
The risk of developing breast cancer is higher in what are known as dense breasts, which appear white in mammograms, than in nondense breasts, which appear grey. Researchers at Linköping University, Sweden, have now shown that there are major biological differences dense breasts and nondense breasts.